Normal carcinoembryonic antigen indicates benefit from perioperative chemotherapy to gastric carcinoma patients

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 29

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

392

HTML

2856

Figures (1-2)

307

Tables (1-4)

255

Sum=3810

Aug 7, 2012 (publication date) through Jan 6, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Aug 7, 2012; 18(29): 3910-3916
Published online Aug 7, 2012. doi: 10.3748/wjg.v18.i29.3910

Table 2 The efficacy of preoperative chemotherapy on locally advanced gastric cancer patients n (%)

	Response to preoperative chemotherapy
Pretreatment serum CEA	Complete response	Partial response	Stable disease	Progressive disease
Normal	3 (7.0)	15 (34.9)	21 (48.8)	4 (9.3)
Elevated	1 (5.9)	4 (23.5)	10 (58.8)	2 (11.8)

CEA: Carcinoembryonic antigen.

Citation: Chen S, Chen YB, Li YF, Feng XY, Zhou ZW, Yuan XH, Qian CN. Normal carcinoembryonic antigen indicates benefit from perioperative chemotherapy to gastric carcinoma patients. World J Gastroenterol 2012; 18(29): 3910-3916
URL: https://www.wjgnet.com/1007-9327/full/v18/i29/3910.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i29.3910